| Product Name | MF | CAS | Details |
|---|
| 4-[(Cyclopropylcarbonyl)amino]benzoic acid | C11H11NO3 | 23745-26-8 | Details |
| Boc-Ala-Ala-Asp-pNA | C21H29N5O9 | 201732-83-4 | Details |
| tert-Butyl 3-amino-1H-pyrazole-5-carboxylate | C8H13N3O2 | 1342836-25-2 | Details |
| Olanzapine-d3 N-oxide | C17H20N4OS | 1189732-75-9 | Details |
| (3-Chlorobenzo[b]thiophen-2-yl)-N-(4-nitrophenyl)formamide | C15H9ClN2O3S | 162090-87-1 | Details |
| 5-Chloro-3-methyl-1-(4-methylphenyl)-1H-pyrazole | C11H11ClN2 | 1266615-39-7 | Details |
| Tris(pentafluorophenyl)borane | C18BF15 | 1109-15-5 | Details |
| Corylin | C20H16O4 | 53947-92-5 | Details |
| 3-Chloro-5-methylbenzaldehyde | C8H7ClO | 103426-20-6 | Details |
| [(4-Nitrophenyl)methyl]hydrazine dihydrochloride | C7H10ClN3O2 | 2044707-11-9 | Details |
| [3-(Propan-2-yl)pyrrolidin-3-yl]methanol | C8H17NO | 1515457-62-1 | Details |
| Renin antibody | Details |
| Methotrexate antibody | Details |
| Luciferase inhibitor I | C14H11N3O2 | 352341-26-5 | Details |
| Darapladib - Bio-X ? | C36H38F4N4O2S | 356057-34-6 | Details |
| FBXO2 protein (His tag) | Details |
| 1,4-dichloro-2-((4-benzylpiperazinyl)sulfonyl)benzene | C17H18Cl2N2O2S | 312282-17-0 | Details |
| tert-Butyl 4-(pyrrolidin-3-yl)piperidine-1-carboxylate | C14H26N2O2 | 1314771-79-3 | Details |
| Tridecanedioic Acid | C13H24O4 | 505-52-2 | Details |
| CUTA antibody | Details |
| 3-Bromo-4-methylbenzenesulfonamide | C7H8BrNO2S | 210824-69-4 | Details |
| 1,2,4,5-Tetramethylimidazole | C7H12N2 | 1739-83-9 | Details |
| SECTM1 Blocking Peptide | Details |
| Methyl 4-isocyanatobutanoate | C6H9NO3 | 27678-30-4 | Details |
| Ustusolate E | C21H26O6 | 1175543-06-2 | Details |
| Butyl[(2-fluorophenyl)methyl]amine hydrochloride | C11H17ClFN | 1049773-05-8 | Details |
| 3,5-Bis(Trifluoromethyl)bromobenzene | C8H3BrF6 | 328-70-1 | Details |
| 2-(4-Methoxyphenyl)propanal | C10H12O2 | 5405-83-4 | Details |
| TAK 733 | C17H15F2IN4O4 | 1035555-63-5 | Details |
| Aristeromycin | C11H15N5O3 | 19186-33-5 | Details |
| Methyl 3-(3-methoxyphenyl)-2-methyl-3-oxopropanoate | C12H14O4 | 343305-12-4 | Details |
| Fmoc L-aspartic acid | C19H17NO6 | 119062-05-4 | Details |
| Purpureaside C | C35H46O20 | 108648-07-3 | Details |
| N-Methyl-4-sulfanylbenzamide | C8H9NOS | 187160-34-5 | Details |
| (3S)-1-(4-Fluorobenzoyl)pyrrolidin-3-amine | C11H13FN2O | 1286207-57-5 | Details |
| 1-(2-Ethylphenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid | C12H12N2O3 | 1152604-56-2 | Details |
| N1,N2,N2-Trimethyl-psi-isocytidine | Details |
| 3-aminopyrrolidin-2-one hcl | C4H8N2O.ClH | 117879-49-9 | Details |
| Dabigatran etexilate - Bio-X ? | C34H41N7O5 | 211915-06-9 | Details |
| Opipramol | C23H29N3O | 315-72-0 | Details |
| 2-(Chloromethyl)-6-ethoxypyridine | C8H10ClNO | 1251129-11-9 | Details |
| 4-{[(tert-Butoxy)carbonyl]amino}oxane-2-carboxylic acid | C11H19NO5 | 1779582-40-9 | Details |
| (2S,4R)-1-(4-tert-Butylbenzenesulfonyl)-4-hydroxypyrrolidine-2-carboxylic acid | C15H21NO5S | 1955473-71-8 | Details |
| 1-Oxa-3-azaspiro[4.4]nonane-2,4-dione | C7H9NO3 | 67852-27-1 | Details |
| NHP2L1 protein (His tag) | Details |
| 3-[2-[4-(5-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | C23H27FN4O2 | 1199589-74-6 | Details |
| 2-Oxokolavenol | C20H32O2 | 130395-82-3 | Details |
| 3-Methyl-5-(trichloromethyl)-1,2,4-oxadiazole | C4H3Cl3N2O | 1195-25-1 | Details |
| N-tert-Butylpiperidine-4-carboxamide hydrochloride | C10H21ClN2O | 1170056-07-1 | Details |
| PDE3A antibody | Details |
| Magainin Spacer Peptide | C97H150N28O39 | Details |
| [Val3]-beta-Casomorphin (1-4) amide (bovine) | Details |
| Sofituzumab | 1418200-58-4 | Details |
| [(2S,4S)-1-Benzyl-4-methoxypyrrolidin-2-yl]methanamine | C13H20N2O | 2171176-74-0 | Details |
| EXOC1 Blocking Peptide | Details |
| ATP6V0E2 Blocking Peptide | Details |
| 2,2,5-Trimethylpyrrolidine hydrochloride | C7H16ClN | 6620-67-3 | Details |
| 2-Amino-3-[4-(trifluoromethyl)phenyl]propanoic acid hydrochloride | C10H11ClF3NO2 | 167496-28-8 | Details |
| CD49e antibody | Details |
| 5-Chloro-2-iodo-3-methoxypyridine | C6H5ClINO | 1261634-88-1 | Details |
| 2-[Methyl(piperidin-3-yl)amino]ethan-1-ol dihydrochloride | C8H19ClN2O | 1219957-18-2 | Details |
| Potassium tartrate dibasic hemihydrate | C4H6K2O7 | 6100-19-2 | Details |
| N-Cyclopropylpiperidin-4-amine dihydrochloride | C8H18Cl2N2 | 1217100-00-9 | Details |
| 1-(4-Methoxy-pyridin-2-yl)-ethanone | C8H9NO2 | 59576-28-2 | Details |
| dibutyl [2-(trifluoromethyl)cyclopropyl]boronate | C12H22BF3O2 | 909698-11-9 | Details |
| 4-Cyclopropylpiperidine-2,6-dione | C8H11NO2 | 1339030-55-5 | Details |
| Fluxapyroxad-N-desmethyl | C17H10F5N3O | 2056235-52-8 | Details |
| c11 Bodipy 581/591 | C30H34BF2N2O2.H | 217075-36-0 | Details |
| 6-[(Difluoromethyl)sulfanyl]-1,2,3,4-tetrahydronaphthalen-1-one | C11H10F2OS | 1240528-46-4 | Details |
| 4-[4-(4-Morpholinyl)butoxy]benzaldehyde hydrochloride | C15H22ClNO3 | 1049756-80-0 | Details |
| MOBKL2A antibody | Details |
| LYPLA2 protein (His tag) | Details |
| RAB21 protein (His tag) | Details |
| 1-(2,5-Dimethylthiophen-3-yl)ethan-1-amine hydrochloride | C8H14ClNS | 857546-95-3 | Details |
| 2-Methyl-1-(5-nitro-1,2,3,4-tetrahydroisoquinolin-2-yl)propan-2-ol | C13H18N2O3 | 1461707-42-5 | Details |
| 3-(2,5-Dimethyl-1-pyrrolyl)phenol | C12H13NO | 97608-33-8 | Details |
| 2-(Pyrimidin-2-yloxy)acetic acid | C6H6N2O3 | 328084-05-5 | Details |
| (3-tert-Butylcyclobutyl)methanol | C9H18O | 1781883-92-8 | Details |
| 2-Chloro-5-formylbenzene-1-sulfonamide | C7H6ClNO3S | 3279-81-0 | Details |
| Gypsogenin | C30H46O4 | 639-14-5 | Details |
| RL648_81 | C17H17F4N3O2 | 1919050-87-5 | Details |
| 6-Chloro-3,4'bipyridine | C10H7ClN2 | 79739-22-3 | Details |
| 3-methyl-1-(2,5-thiazolyl)-3-pyrroline-2,5-dione | C8H6N2O2S | 1022803-10-6 | Details |
| N,N-Dimethyl-2-(3-methyl-5-sulfanyl-4H-1,2,4-triazol-4-yl)acetamide | C7H12N4OS | 353286-93-8 | Details |
| INSL5 | Details |
| 6-Methyl-4-oxo-1-[3-(trifluoromethyl)phenyl]-1,4-dihydropyridazine-3-carboxylic acid | C13H9F3N2O3 | 133221-31-5 | Details |
| Lipocalin 12 Blocking Peptide | Details |
| 4-(Aminomethyl)-2-methoxyaniline dihydrochloride | 2225146-89-2 | Details |
| Mca-(Asn670,Leu671)-Amyloid beta/A4 Protein Precursor770 (669-674)-Lys(Dnp) | C51H67N11O21 | 1802078-34-7 | Details |
| Ethyl 2-amino-2-cyclobutylacetate hydrochloride | C8H16ClNO2 | 2173996-41-1 | Details |
| 2-Bromo-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole | C11H11BrN2O4 | 926191-64-2 | Details |
| LEWIGEIDPSESNTNYNQK* - SIL Vedolozumab signature peptide quantifier | Details |
| Gentamicin-BSA | Details |
| 2-Deoxycytidine 3',5'-diphosphate sodium salt | C9H15N3O10P2.4Na | 110972-30-0 | Details |
| BAG5 Blocking Peptide | Details |
| 5-Amino-2-methyl-N-(propan-2-yl)benzamide | C11H16N2O | 1249670-98-1 | Details |
| Methyl 3-methyl-1,2-benzoxazole-6-carboxylate | C10H9NO3 | 478169-71-0 | Details |
| CONSENSUS B Tat - 01 | C81H122N22O22S | Details |
| 1-?Piperazineacetamide, N-?(tetrahydro-?1,?1-?dioxido-?3-?thienyl)?-?, hydrochloride | C10H19N3O3S.2[HCl] | 1315369-09-5 | Details |
| 1,4:3,6-Dianhydro-L-iditol | C6H10O4 | 24332-71-6 | Details |
| Product Total： Product Page： | ||||
| 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 | ||||